BRANDI TRUJILLO: Open Payments
NPI 1467824433 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 71 payments from 19 companies in 2025. Trend: 2023 $602 · 2024 $1,075 · 2025 $1,497
Food & beverage: $1,497
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $318 |
| GlaxoSmithKline, LLC. | 17 | $301 |
| Insmed, Inc. | 12 | $262 |
| Regeneron Healthcare Solutions, Inc. | 6 | $104 |
| Verona Pharma, Inc. | 3 | $66 |
| Viatris Specialty LLC | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| GENZYME CORPORATION | 2 | $53 |
| Amgen Inc. | 3 | $45 |
| ANI Pharmaceuticals, Inc. | 2 | $41 |
Products named: AIRSUPRA, Arikayce, TRELEGY ELLIPTA, DUPIXENT, NUCALA, FASENRA, Ohtuvayre, TEZSPIRE.
Industry payments across TX — which companies pay providers there.
